HI BD
What's your opinion about the rest of the compounds still on test?
When test suggests " showing activity", what need to be done by MM et al. to monetise the compounds?
BIT's outcome needs to be timely and fast tracked, why are MM et al. too slow?
Why no publicity by CMO?
What's the point of increasing the library with the compounds that tend to be obsolete before get monetized?
Any shed of lights, buddy? Stay Safe, be critical of and not silent of BIT!
Ann: Quarterly Activities Report, page-32
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
